[HTML][HTML] Changes in glutathione content in liver diseases: an update
Glutathione (GSH), a tripeptide particularly concentrated in the liver, is the most important
thiol reducing agent involved in the modulation of redox processes. It has also been …
thiol reducing agent involved in the modulation of redox processes. It has also been …
Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and …
TM Al-Noshokaty, NM Mesbah, DM Abo-Elmatty… - Life Sciences, 2022 - Elsevier
Aims The first-line treatment for advanced hepatocellular carcinoma (HCC) is the
multikinase inhibitor sorafenib (SOR). Sofafenib resistance is linked to protein kinase …
multikinase inhibitor sorafenib (SOR). Sofafenib resistance is linked to protein kinase …
Design of a new self-assembling antioxidant nanomedicine to ameliorate oxidative stress in zebrafish embryos
B Shashni, J Tamaoki, M Kobayashi, Y Nagasaki - Acta Biomaterialia, 2023 - Elsevier
Oxidative stress, which is a persistent state of elevated reactive oxygen species (ROS), is
implicated in the pathogeneses of several diseases, making antioxidant-based therapeutics …
implicated in the pathogeneses of several diseases, making antioxidant-based therapeutics …
Diminished CCl4‐induced hepatocellular carcinoma, oxidative stress, and apoptosis by co‐administration of curcumin or selenium in mice
A Elkhamesy, M Refaat, MSO Gouida… - Journal of Food …, 2022 - Wiley Online Library
Hepatocellular carcinoma (HCC) is a lethal disease, and in HCC advanced stages, there is
limited therapeutic efficacy. HCC results in a complication of fibrosis or cirrhosis. In this …
limited therapeutic efficacy. HCC results in a complication of fibrosis or cirrhosis. In this …
[PDF][PDF] Diminished CCl
A Elkhamesy, M Refaat, MSO Gouida, SS Alrdahe… - 2021 - researchgate.net
Hepatocellular carcinoma (HCC) is a lethal disease, and in HCC advanced stages, there is
limited therapeutic efficacy. HCC results in a complication of fibrosis or cirrhosis. In this …
limited therapeutic efficacy. HCC results in a complication of fibrosis or cirrhosis. In this …
Исследование антиоксидантных свойств наноструктурного клатратного комплекса селенопирана с β-циклодекстрином в модельных системах оксидативного …
ЛА Дзиковская, ЕС Дегтярева, ПВ Шегай… - … биологии и медицины, 2021 - elibrary.ru
Исследовано влияние наноструктурного клатратного комплекса 9-фенил-симм-
октагидроселеноксантена (селенопирана) с β-циклодекстрином на генерацию ОН …
октагидроселеноксантена (селенопирана) с β-циклодекстрином на генерацию ОН …